Establishment Labs Holdings Inc

In a Stage 2 advancing environment with both long- and short-term uptrends and a strong Parabola acceleration pattern, the medium-term bias remains bullish. However, overbought status and near-term exhaustion candle overlays signal a pullback risk. Execution should be deferred until price stabilizes and pulls back into rising EMAs or prior support zones to maintain favorable risk dynamics.

• ↑Q1 revenue $59.9M (+45% YoY); US sales +216% to $19.6M
• ↑Adjusted EBITDA of $1.2M with 70.7% gross margin and $68.1M cash
• ↓Elevated debt levels raise refinancing and downturn vulnerability